RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+5.51%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$558M
AUM Growth
+$558M
(+29%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
20.56%
Top 10 Holdings %
Top 10 Hldgs %
37.3%
Holding
93
New
18
Increased
51
Reduced
4
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$27.5M |
| 2 |
Medtronic
MDT
|
$26.5M |
| 3 |
Cigna
CI
|
$8.74M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$8.09M |
| 5 |
AET
Aetna Inc
AET
|
$7.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$24.6M |
| 2 |
UnitedHealth
UNH
|
$14.8M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$11.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$9.64M |
| 5 |
AbbVie
ABBV
|
$4.8M |
Sector Composition
| 1 | Healthcare | 75.87% |
| 2 | Industrials | 2.28% |
| 3 | Financials | 1.34% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBX
51
DELISTED
CYBERONICS INC
CYBX
| $4.03M | 0.72% |
+64,500
| New | +$4.03M |
|
|
AVNR
52
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $3.95M | 0.71% |
700,000
+400,000
| +133% | +$2.26M |
|
|
MDCO
53
DELISTED
Medicines Co
MDCO
| $3.93M | 0.7% |
135,100
+15,100
| +13% | +$439K |
|
|
WCG
54
DELISTED
Wellcare Health Plans, Inc.
WCG
| $3.85M | 0.69% |
51,500
| – | – |
|
55
Charles River Laboratories
CRL
$7.99B
| $3.81M | 0.68% |
71,250
+21,750
| +44% | +$1.16M |
|
|
ABCO
56
DELISTED
Advisory Board Co/The
ABCO
| $3.76M | 0.67% |
72,500
+41,425
| +133% | +$2.15M |
|
|
CVD
57
DELISTED
COVANCE INC.
CVD
| $3.68M | 0.66% |
43,000
+10,500
| +32% | +$899K |
|
|
ICPT
58
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.57M | 0.64% |
15,100
+2,100
| +16% | +$497K |
|
|
ARAV
59
DELISTED
Aravive, Inc. Common Stock
ARAV
| $3.48M | 0.62% |
+20,709
| New | +$3.48M |
|
60
Prothena Corp
PRTA
$452M
| $3.38M | 0.61% |
150,000
+85,000
| +131% | +$1.92M |
|
61
Tandem Diabetes Care
TNDM
$834M
| $3.17M | 0.57% |
+19,500
| New | +$3.17M |
|
|
WX
62
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $3.17M | 0.57% |
96,500
+44,000
| +84% | +$1.45M |
|
|
RLYP
63
DELISTED
RELYPSA INC COM
RLYP
| $3.06M | 0.55% |
+126,000
| New | +$3.06M |
|
|
CFN
64
DELISTED
CAREFUSION CORPORATION
CFN
| $3.02M | 0.54% |
+68,000
| New | +$3.02M |
|
65
Ultragenyx Pharmaceutical
RARE
$3.04B
| $2.94M | 0.53% |
65,500
+14,000
| +27% | +$628K |
|
|
AGN
66
DELISTED
ALLERGAN INC
AGN
| $2.75M | 0.49% |
+16,250
| New | +$2.75M |
|
|
CBST
67
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $2.72M | 0.49% |
39,000
+9,000
| +30% | +$628K |
|
68
Novavax
NVAX
$1.2B
| $2.63M | 0.47% |
28,500
+12,250
| +75% | +$1.13M |
|
69
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.12M | 0.38% |
7,500
| – | – |
|
70
Alkermes
ALKS
$4.95B
| $2.08M | 0.37% |
41,250
+5,750
| +16% | +$289K |
|
|
FPRX
71
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.94M | 0.35% |
125,000
-50,000
| -29% | -$778K |
|
|
INFI
72
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.94M | 0.35% |
152,500
+55,000
| +56% | +$701K |
|
73
Arrowhead Research
ARWR
$3.84B
| $1.65M | 0.3% |
115,000
+40,000
| +53% | +$573K |
|
74
Theravance Biopharma
TBPH
$691M
| $1.59M | 0.29% |
+50,000
| New | +$1.59M |
|
|
NVDQ
75
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.48M | 0.27% |
+90,000
| New | +$1.48M |
|